Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AIDS Malignancy Consortium A Trial of the AIDS Malignancy Consortium (AMC)

NCT05510908 is registered in ClinicalTrials.gov with AIDS Malignancy Consortium as lead sponsor.

NCT NCT05510908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05510908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AIDS Malignancy Consortium A Trial of the AIDS Malignancy Consortium (AMC)
Lead sponsor
AIDS Malignancy Consortium
Phase
Observational
Overall status
Completed
Start date
July 25, 2023
Completion date
June 2, 2025
Enrollment
460 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

aids related lymphoma, aids-related kaposi sarcoma, aids-related malignancy, anal cancer, cancer, hiv infections, hiv-associated malignant neoplasm, hpv-related malignancy